News | MDBilling

REad the Latest

September 8, 2021

GET A QUOTE ALL POSTS Billing for the coronavirus Vaccine Facebook Twitter Linkedin The American Medical Association has released two

New Part D Policies Address Opioid Epidemic
New Part D Policies Address Opioid Epidemic Early last year, the Centers for Medicare & Medicaid Services (CMS) published a roadmap outlining our efforts to address the national opioid epidemic. The roadmap details our three-pronged approach, including prevention of new cases of opioid use disorder (OUD), expanding access to treatment for patients who have already […]
Continuing Progress in the Fight against the Opioid Crisis
The COVID-19 pandemic has taken a devastating toll on Americans across the country, whether in lives lost or economic impacts, and it has particularly affected our fellow citizens who have the most vulnerabilities, including the elderly and communities of color. We’ve been forced to adjust and adapt our daily lives in innumerable ways, while significant […]
Blog Archive
All CMS.gov blog entries have been archived. You can view previous blog entries by visiting the CMS.gov Blog Archive.

Trends 2025: The demand for interim revenue cycle executives December 20, 2024
The search for revenue cycle management leaders is ongoing and can be particularly challenging because of the nature of the executives who take on the job, according to one expert. "These leaders often have a fix-it mentally," according to Adam Burns, a principal at WittKieffer, an executive search firm for healthcare.
Advocate spending $1 billion on new hospital and outpatient services December 20, 2024
Chicago-based Advocate Health Care is planning to spend $1 billion to improve access to primary and specialty care, as well as wellness services, by investing in a new hospital and extended outpatient programs. The investment will improve access to primary and specialty care, as well as wellness services, the health system said.
To get a merger through, think about access to care December 20, 2024
The FTC is not targeting private equity or trying to impede investment in healthcare, it's just looking at anticompetitive conduct, says John Saran, a partner at Holland & Knight.

We focus on billing so you can focus on patient care